Medicamen Biotech opened higher at ₹300.00, compared with its previous close of ₹299.45. During today's session, the stock has traded between ₹290.05 and ₹306.00, with an average traded price of ₹296.07. It is currently showing a sideways intraday trend.
An investment of ₹10,000 made 5 years ago in Medicamen Biotech is now worth
₹ 5,409.00
resulting in a loss of
₹ 4,591.00 (45.91%)
Note: Past profits do not guarantee future returns.
No analyst rating data available.
Today's Change
-0.90 (-0.30%)
Day High
₹306.00
Day Low
₹290.05
Day Open
₹300.00
Prev Close
₹299.45
Volume
11,474
Value Traded
₹0.34 Cr
1W Return
-3.07%
1M Return
-7.58%
3M Return
21.68%
6M Return
23.78%
1Y Return
-3.68%
Market Cap (₹ Cr.)
405
PE Ratio
41.10
PB Ratio
1.55
Dividend Yield
0.33%
ROE
3.56%
ROCE
5.45%
Book Value (₹)
196.82
Face Value (₹)
10.00
EPS (TTM)
1.36
Industry PE
-
Beta
-
Debt to Equity
-
1 Week
-3.07%
6 Week
-
1 Month
-7.58%
3 Month
21.68%
9 Month
-24.60%
Medicamen Biotech shareholders approve all AGM resolutions
All eight AGM resolutions passed with 99.999% votes in favor. 184 shareholders participated via video conferencing. Promoter group votes excluded for related-party transaction items. FY26 financial statements and dividend declaration approved.
15 days agoMedicamen Biotech recommends Re.1 dividend ahead of Sep 26 AGM
Medicamen Biotech schedules its 33rd AGM for September 26, 2026. Board recommends a dividend of Re.1.00 per equity share. Remote e-voting runs from September 23 to September 25, 2026. Shareholders on record as of September 19, 2026 are eligible.
1mo agoMedicamen Biotech submits FY26 BRSR report detailing ₹1,788.5 crore turnover
Medicamen Biotech reported a total turnover of ₹1,788.46 crore for FY26. Profit after tax stood at ₹94.09 crore for the financial year ended March 2026. International markets contributed approximately 80% of total sales revenue. The company incurred ₹25.20 lakh on CSR projects against a requirement of ₹31.33 lakh. A penalty of ₹7,080 was paid to NSE for delayed shareholding pattern filing.
1mo agoMedicamen Biotech fixes Sept 19 record date for FY26 final dividend
Medicamen Biotech Limited announced a record date of September 19, 2026, for its FY26 final dividend. The register of members will close from September 20 to 26, 2026, for the 33rd AGM. The payout awaits shareholder approval.
1mo agoMedicamen Biotech Q1FY27 standalone net profit up 54% to ₹252.69 lakh
Medicamen Biotech reported a 54% YoY rise in standalone net profit to ₹252.69 lakh for Q1FY27, driven by 14% revenue growth. The board approved the results and recommended a 10% dividend.
1mo agoShivalik Rasayan holds 40.46% stake in Medicamen Biotech
Promoter Shivalik Rasayan Limited holds 54,87,095 equity shares, or 40.46%, in Medicamen Biotech Limited as of March 31, 2026. The company confirmed that no shares were encumbered during the financial year 2025-26.
3mo ago| Stock | LTP | Change % | Market Cap (Cr.) | PE | 1Y Return |
|---|---|---|---|---|---|
| ₹1,770.70 | +0.61% | ₹4,24,850.24 | 34.83 | +5.97% | |
| ₹9,285.00 | -1.50% | ₹2,46,487.58 | 85.12 | +43.41% | |
| ₹4,642.90 | -0.84% | ₹1,76,600.99 | 82.55 | +31.42% | |
| ₹1,132.50 | -0.17% | ₹1,12,967.31 | 24.74 | +14.00% | |
| ₹2,059.40 | -0.47% | ₹1,11,271.90 | 102.63 | +134.89% | |
| ₹1,329.60 | +1.40% | ₹1,07,412.86 | 31.62 | -14.87% | |
| ₹1,240.00 | +0.86% | ₹1,03,500.36 | 32.26 | -1.93% | |
| ₹2,372.00 | -1.17% | ₹97,974.30 | 47.92 | -3.57% | |
| ₹1,684.60 | -1.31% | ₹96,928.16 | 26.40 | +49.04% | |
| ₹1,953.60 | +0.96% | ₹89,336.17 | 16.03 | -0.29% | |
| ₹2,265.30 | -0.78% | ₹63,932.35 | 35.82 | +16.81% | |
| ₹5,250.00 | +0.86% | ₹62,771.63 | 28.34 | -3.75% |
An investment of ₹10,000 made 5 years ago in Medicamen Biotech is now worth
₹ 5,409.00
resulting in a loss of
₹ 4,591.00 (45.91%)
Note: Past profits do not guarantee future returns.
